Code | CSB-MP005506HU |
Abbreviation | Recombinant Human CLDN4 protein-VLPs (Active) |
MSDS | |
Size | $570 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
This Human Claudin-4 (CLDN4) recombinant protein was produced in mammalian cell, where the gene sequence encoding human CLDN4 (1-209aa) was expressed with the C-terminal 10xHis tag. The activity was validated.
In addition, this recombinant human CLDN4 protein was developed through the Virus-Like Particles (VLPs) Platform. It is a four-pass transmembrane protein.
Both CLDN4 and CLDN8 are considered to be cation barriers and anion channels. We found that catheter-specific knockout of CLDN4 caused hypotension, hypochloremia, metabolic alkalosis, and renal failure symptoms of Na+ and Cl−, and overexpression of CLDN4 resulted in cation-selective MDCK II and anion-selective LLC-PK1 TER was increased in cells, and a decrease in Na+ permeability was observed in MDCK II cells.
In diabetes, CLDN4 is overexpressed in the distal nephron of type 1 diabetic rats mediated by divergent aldosterone levels, and the expression of WNK4 and its colocalization with CLDN4 and CLDN8 are also increased. This may lead to increased activation of CLDN4 and CLDN8 by WNK4 under diabetic conditions.
There are currently no reviews for this product.